Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Psilocybin”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT06988319
What this trial is testing

Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility Study

Who this might be right for
Chronic Pelvic Pain
Oregon Health and Science University 15
Very early researchLooking for participantsNCT04123314
What this trial is testing

Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease

Who this might be right for
Depressive SymptomsDepressionAlzheimer Disease+1 more
Johns Hopkins University 20
Testing effectiveness (Phase 2)Looking for participantsNCT06319378
What this trial is testing

Cancer Related Major Depression Treated With a Single Dose of Psilocybin

Who this might be right for
MDD
Section for Affective Disorders; Northern Stockholm Psychiatry 100
Testing effectiveness (Phase 2)Looking for participantsNCT07216404
What this trial is testing

Psilocybin-Assisted Therapy for the Treatment of Major Depressive Disorder in Patients With Non-Small Cell Lung Cancer

Who this might be right for
Lung Non-Small Cell CarcinomaUnipolar Depression
Alan Davis 10
Testing effectiveness (Phase 2)Looking for participantsNCT07610135
What this trial is testing

Psilocybin Efficacy With or Without Pimavanserin Pretreatment

Who this might be right for
Mood (Psychological Function)Well BeingMood+1 more
Johns Hopkins University 20
Not applicableStudy completedNCT05581797
What this trial is testing

Psilocybin-assisted Interpersonal Therapy for Depression

Who this might be right for
Depressive Disorder, Treatment-Resistant
University of Otago 5
Early research (Phase 1)Active Not RecruitingNCT06299319
What this trial is testing

Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant OCD

Who this might be right for
Obsessive-Compulsive Disorder
Centre for Addiction and Mental Health 10
Early research (Phase 1)Study completedNCT07710027
What this trial is testing

Identification of a Safe and Non-Psychedelic Dose of Psilocybin

Who this might be right for
Healthy Controls
Diamond Therapeutics Inc. 56
Testing effectiveness (Phase 2)Study completedNCT06746441
What this trial is testing

Effect of Psilocybin Only and Psilocybin Assisted Cognitive Behavioral Therapy in the Management of Major Depressive Disorder and Associated Metabolic, Immune, Inflammatory, Neuroplasticity and Electrical Activity Markers

Who this might be right for
Major Depressive Disorder
Khyber Medical University Peshawar 60
Early research (Phase 1)Study completedNCT02981173
What this trial is testing

Psilocybin for the Treatment of Cluster Headache

Who this might be right for
Cluster Headache
Yale University 25
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07721467
What this trial is testing

Neuroplasticity Enhancement From Cognitive Training Reinforced by Psilocybin

Who this might be right for
Alzheimer's Disease
National Institute on Aging (NIA) 200
Very early researchWithdrawnNCT05227742
What this trial is testing

Exploratory Study of Low Dose Psilocybin

Who this might be right for
Demoralization
University of Alabama at Birmingham
Testing effectiveness (Phase 2)Study completedNCT04141501
What this trial is testing

Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients

Who this might be right for
Alcohol Use Disorder
University of Zurich 37
Early research (Phase 1)Study completedNCT05592379
What this trial is testing

Consciousness, Psilocybin, and Well-Being

Who this might be right for
HealthyPsychedelic ExperiencesSleep
University of Wisconsin, Madison 6
Testing effectiveness (Phase 2)Study completedNCT02971605
What this trial is testing

Persisting Effects of Psilocybin

Who this might be right for
Healthy
Johns Hopkins University 13
Testing effectiveness (Phase 2)Active Not RecruitingNCT05947383
What this trial is testing

Two Doses of Psilocybin for the Treatment of MDD in Adults With Cancer

Who this might be right for
CancerMajor Depressive Disorder
Sunstone Medical 56
Testing effectiveness (Phase 2)Active Not RecruitingNCT05554094
What this trial is testing

Psilocybin for the Treatment of Veterans With Post-Traumatic Stress Disorder

Who this might be right for
PTSDStress Disorders, TraumaticStress Disorders, Post-Traumatic+2 more
Ohio State University 15
Not applicableStudy completedNCT04519957
What this trial is testing

Long Term Follow Up Study to COMP 001 And COMP 003 Trials (P-TRD LTFU)

Who this might be right for
Treatment Resistant Depression
COMPASS Pathways 66
Testing effectiveness (Phase 2)Looking for participantsNCT06969170
What this trial is testing

Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder

Who this might be right for
Generalized Anxiety Disorder (GAD)
Claudio N Soares 50
Early research (Phase 1)Looking for participantsNCT07386730
What this trial is testing

Psychedelics in Healthy Older Adults With Low Well-being

Who this might be right for
Anhedonia in Healthy VolunteersOlder Adults (50-90 Years)
Jennifer Mitchell 80
Next Page